Stellixir Biotech is known to develop disease models that best suit your R&D needs. Cell based assays and cell-based screening are of key importance at a number of stages in the drug discovery process. We work on simultaneous visualization and prominently feature real monitoring to identify the toxicity responses. We have developed and screened compounds using cell-based assays for over a decade.
Our knowledge and skills in cell culture, combined with our expertise in developing cell-based assays allow us to work rapidly and efficiently on the prosecution of your target by using appropriate screening methods.
Stellixir Biotech makes use of Herbal extracts, synthetic chemicals, nanomaterials, metals of biomedical devices, Exosomes, small and large molecules etc. as per the requirement of the client.
We provide various bioassays platforms to facilitate research in various fields like oncology, metabolic disorders, neurodegenerative and cardiovascular diseases by using 2D and 3D in vitro models. We offer high-throughput drug screening services by using flow cytometry, confocal microscopy, RTqPCR and NGS for the following diseases: